Will the Russian cancer vaccine work?

The market shows low confidence in the effectiveness of the Russian cancer vaccine.

Current market probabilities indicate a strong skepticism regarding the Russian cancer vaccine's efficacy, with 84.18% betting against its success. The Pulse AI suggests a slightly higher probability for success at 20.82%, but overall confidence remains low at 45 out of 100. The market appears fairly priced, indicating balanced views among participants.

• 1 Market probability for success is low at 15.82%.
• 2 Pulse AI indicates a slightly higher probability at 20.82%.
• 3 The market is assessed as fairly priced with an edge of 5.
• 4 Confidence level is moderate at 45 out of 100.
• 5 Time to expiry is significant at 41802 hours, allowing for potential developments.